Visceral pain is one of the most common type of pain in mammals, however its mechanisms of action has not clearly been understood. In common sense, prostaglandins are released depending on tissue damage to reduce the threshold of pain receptors. Thus, pharmacological inhibition of c-Raf kinase signaling PDF
Drug abuse is a serious challenge in US. According to the report of the Drug Abuse Warning Network, more than 50% of the patients involved the abuse of control pharmaceuticals such as taking more than the prescribed dose of a prescription [1]. A more serious concern is that the control pharmaceuticals was taken by healthy individuals. This challenge is more specific in pain management with opioids such as morphine, oxycodone, oxymorphone, hydrocodone, hydromorphone, dihydrocodeine, methadone, meperidine, fentanyl, and buprenorphine. PDF
Dr. Joseph Smith has after many years of research submitting a new development after being picked in April 17-20, 2010 by the SAWC for an Oral Award on my first patent, developed a patented engineered design in addition to (US PAT. # 6776769 BS 2 an application of a cap (US201201363A1), in Advanced Wound Care, Pharma, Biologics that offers better protection for people PDF
This paper looks at organizational changes in the pharmaceutical industry's environment using the classic Kotter (1996) 8 Step model and has made an argument that the model can be used successfully in regulatory science learning. The literature on both change management and regulatory science learning was reviewed to see how both topics related to Kotter's 8 Step model. PDF
An estimated 0.6-1.5% of the U.S. population is affected by neuropathic pain as reported by the American Academy of Pain Management. Currently, neuropathic pain management involves drug combination therapy. Compounding pharmacy plays a key role in meeting the demand for an increasing need for individualized and easily accessible drug preparations. To date, information PDF